The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Eyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution

European Regulatory Affairs t/a IvowenPA23156/005/001

Main Information

Trade NameEyzeetan 0.3 mg/ml + 5 mg/ml eye drops, solution
Active SubstancesBimatoprost
Timolol Maleate
Dosage FormEye drops, solution
Licence HolderEuropean Regulatory Affairs t/a Ivowen
Licence NumberPA23156/005/001

Group Information

ATC CodeS01ED51 timolol, combinations


License statusAuthorised
Licence Issued01/11/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back